Related Experiment Video
Updated: May 5, 2026
An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Uncovering HIV and malaria interactions: the latest evidence and knowledge gaps
Antía Figueroa-Romero1, Anna Saura-Lázaro2, Sheila Fernández-Luis3
1Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Abstract:
The geographical distribution of malaria and HIV infections widely overlap in sub-Saharan Africa, constituting a complex global health challenge. The interplay between both infections raises concerns about potential immunological, clinical, and therapeutic interactions. Both diseases have been reported to exacerbate the transmission of the other, including the possible vertical transmission of HIV in pregnant individuals with malaria. Co-infection also increases the risk of adverse outcomes such as severe malaria and death. In addition, interactions between antiretroviral and antimalarial drugs have been reported, potentially reducing the efficacy of these drugs. We review the current knowledge of the epidemiological, clinical, immunological, and therapeutic interactions of both infections. We focus on the latest available data and identify key knowledge gaps that should be addressed to guide policy makers in providing optimal HIV and malaria prevention, care, and treatment in vulnerable populations.
Insights
Malaria and HIV co-infection in sub-Saharan Africa presents significant health risks, increasing disease transmission and adverse outcomes. Understanding these interactions is crucial for effective prevention and treatment strategies.
Area of Science:
- Global Health
- Infectious Diseases
- Immunology
Background:
- Malaria and HIV infections overlap geographically in sub-Saharan Africa.
- Co-infection poses complex immunological, clinical, and therapeutic challenges.
- Both diseases can exacerbate each other's transmission and increase mortality risk.
Purpose of the Study:
- To review current knowledge on the interactions between malaria and HIV.
- To focus on epidemiological, clinical, immunological, and therapeutic aspects.
- To identify knowledge gaps for policy makers.
Main Methods:
- Literature review of current data on malaria and HIV interactions.
- Analysis of epidemiological, clinical, and immunological data.
- Assessment of therapeutic drug interactions.
Main Results:
- Co-infection increases transmission, including vertical HIV transmission.
- Adverse outcomes like severe malaria and death are more likely.
- Drug interactions between antiretrovirals and antimalarials can reduce efficacy.
Conclusions:
- Effective prevention, care, and treatment strategies are needed for co-infected populations.
- Addressing knowledge gaps is essential for policy development.
- Optimizing care for vulnerable populations requires integrated approaches.
More Related Videos
Related Concept Videos
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
01:28Infectious Diseases and Their Occurrence